Skip to main content
Clinical Trials/NCT07650877
NCT07650877RecruitingNot Applicable

Comparison of the Effects of Ultrasound-Guided Rhomboid Intercostal Block and Serratus Posterior Superior Intercostal Plane Block on Postoperative Acute Pain in Patients Undergoing Video-Assisted Thoracoscopic Surgery

Ankara City Hospital Bilkent1 site in 1 country90 target enrollmentStarted: June 15, 2026Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
90
Locations
1
Primary Endpoint
Surgical Pain Scores

Study Overview

Brief Summary

Video-assisted thoracic surgery (VATS) is widely performed for the management of various thoracic pathologies and is generally associated with reduced surgical trauma compared with open thoracotomy. Nevertheless, patients may still experience considerable postoperative pain, which can adversely affect respiratory function, mobilization, and recovery. Various regional analgesic techniques have been incorporated into multimodal pain management strategies for VATS, including thoracic paravertebral block (TPVB), erector spinae plane block (ESPB), intercostal nerve block, serratus anterior plane block (SAPB), rhomboid intercostal block (RIB), and serratus posterior superior intercostal plane block (SPSIPB). Among these approaches, ultrasound-guided TPVB has traditionally been regarded as a reference regional analgesic technique. More recently, interfascial plane blocks have gained increasing attention because of their technical simplicity and favorable safety profile. RIB and SPSIPB are two novel interfascial plane blocks that may provide effective postoperative analgesia following thoracic surgery. The present study aims to compare the analgesic efficacy of RIB and SPSIPB in patients undergoing VATS and to evaluate their impact on postoperative pain outcomes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients undergoing elective VATS
  • Patients aged 18-75 years
  • Patients with ASA (American Society of Anesthesiologists) class I-III
  • Patients who have given informed consent

Exclusion Criteria

  • Patients allergic to local anesthetics
  • Patients with bleeding disorders or those undergoing anticoagulant therapy
  • Pregnant and breastfeeding women
  • Patients with impaired consciousness, inability to communicate, or mental/cognitive impairment
  • Patients who refuse block application
  • Patients with infection in the area where the block will be applied

Arms & Interventions

Rhomboid Intercostal Block

Active Comparator

For patients scheduled to receive a Rhomboid Intercostal Block (RIB), after sonographic identification of the relevant anatomical structures, the block needle is advanced using an in-plane ultrasound-guided technique beneath the rhomboid muscle until contact with the rib is achieved. Following hydrodissection with 2 mL of normal saline to confirm correct needle placement, 30 mL of 0.25% bupivacaine is injected into the interfascial plane.

Intervention: Rhomboid Intercostal Block (Drug)

Serratus Posterior Superior Intercostal Plane Block

Active Comparator

For patients scheduled to receive a Serratus Posterior Superior Intercostal Plane Block (SPSIPB), after sonographic identification of the relevant anatomical structures, the block needle is advanced using an in-plane ultrasound-guided technique beneath the serratus posterior superior muscle until contact with the rib is achieved. Following hydrodissection with 2 mL of normal saline to confirm correct needle placement, 30 mL of 0.25% bupivacaine is injected into the interfascial plane.

Intervention: Serratus Posterior Superior Intercostal Plane Block (Drug)

Outcomes

Primary Outcomes

Surgical Pain Scores

Time Frame: 24 hours after surgery

Surgical pain will be assessed at rest and while coughing using the visual analog scale on a scale from 0mm (no pain) to 100mm (worst pain). Pain assessment will be done at 1st, 6th, 12th, and 24th hours after surgery.

Secondary Outcomes

  • Shoulder Pain Scores(24 hours after surgery)
  • Intraoperative remifentanil consumption(During the intraoperative period)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Nilgün Zengin

Principal İnvestigator

Ankara City Hospital Bilkent

Study Sites (1)

Loading locations...

Similar Trials